Aventis, Sun Settle Pair Of Allegra Generic Suits

Law360, New York (July 19, 2011, 5:44 PM ET) -- Aventis Pharmaceuticals Inc. on Monday settled with generics maker Sun Pharmaceutical Industries Ltd. in two New Jersey suits over a proposed generic version of the allergy drug Allegra, which Aventis claimed would infringe eight of its patents for the medication.

Details of the deal were not immediately available, and attorneys for the parties did not immediately respond to requests for comment Tuesday.

The two suits, filed in January and October 2009 respectively, largely make the same allegations against India-based Sun and its affiliates, though they are...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required